FDA to restrict CFC inhalers to meet US environmental goals
This article was originally published in Clinica
Executive Summary
The FDA has proposed curbs in the use of chlorofluorocarbon (CFC) propellants in metered-dose inhalers to begin meeting the US goal of eventually phasing out all applications of the ozone-depleting substance.